Australia markets close in 50 minutes

Santhera Pharmaceuticals Holding AG (SPHDF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
11.700.00 (0.00%)
At close: 01:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 121.68M
Enterprise value 165.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.26
Price/book (mrq)N/A
Enterprise value/revenue 32.04
Enterprise value/EBITDA -4.70

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 31,620.59%
S&P500 52-week change 321.08%
52-week high 313.35
52-week low 30.68
50-day moving average 311.65
200-day moving average 38.94

Share statistics

Avg vol (3-month) 345
Avg vol (10-day) 3250
Shares outstanding 511.68M
Implied shares outstanding 611.74M
Float 84.46M
% held by insiders 121.79%
% held by institutions 13.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 303 July 2023

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-515.49%

Management effectiveness

Return on assets (ttm)-37.31%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.16M
Revenue per share (ttm)0.58
Quarterly revenue growth (yoy)-37.00%
Gross profit (ttm)N/A
EBITDA -39.42M
Net income avi to common (ttm)-64.69M
Diluted EPS (ttm)-9.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.67M
Total cash per share (mrq)0.18
Total debt (mrq)41.51M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.14
Book value per share (mrq)-4.65

Cash flow statement

Operating cash flow (ttm)-33.24M
Levered free cash flow (ttm)-8.97M